Medicinal Chemistry Research

, Volume 23, Issue 3, pp 1123–1147 | Cite as

Synthesis, characterization, biological activity, and 3D-QSAR studies on some novel class of pyrrole derivatives as antitubercular agents

  • Shrinivas D. Joshi
  • Uttam A. More
  • Sheshagiri R. Dixit
  • Haresh H. Korat
  • Tejraj M. Aminabhavi
  • Aravind M. Badiger
Original Research


A new series of pyrrole derivatives have been designed, synthesized, and their structures have been elucidated along with the evaluation of antitubercular activity against Mycobacterium tuberculosis H37Rv using the microplate alamar blue assay method and antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, and Escherichia coli by broth micro-dilution assay method. Structural activity relationships and 3D-QSAR analysis have been carried out by Topomer Comparative Molecular Field Analysis (CoMFA). Training set of 42 and test set of 8 active compounds were used to develop the method that showed cross-validated correlation coefficient (q 2) of 0.815, standard error of prediction of 0.36, non-cross-validated correlation coefficient (r 2) of 0.973, and standard error of estimate of 0.14 with six components.

Graphical Abstract

Synthesis; spectral and 3D-QSAR studies; and antibacterial, antitubercular, and cytotoxic activities of a novel series of pyrrole derivatives are described.


Pyrroles Antibacterial activity Antitubercular activity Broth dilution assay method Cytotoxicity Topomer CoMFA 



Authors immensely thank the Indian Council of Medical Research, New Delhi, India for financial support [File No. 64/4/2011-BMS, IRIS Cell No. 2010-08710]. We also thank Dr. V. H. Kulkarni, Principal and Mr. H. V. Dambal, President, S.E.T.’s College of Pharmacy, Dharwad, India, for providing facilities. We thank Dr. K. G. Bhat, Maratha Mandal’s Dental College, Hospital and Research Centre, Belgaum, India for providing facilities for antibacterial, antitubercular, and cytotoxic activities; Director, SAIF, Indian Institute of Technology, Chennai, Tamil Nadu, India and the Director, SAIF, Panjab University, Chandigarh, Panjab, India for providing the NMR and mass spectral data. We thank Mr. Shrikant A. Tiwari for his technical assistance.


  1. Abdel-Aziz AA (2007) Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study. Eur J Med Chem 42:614–626CrossRefPubMedGoogle Scholar
  2. Ahmadi A, Solati J, Hajikhani R, Pakzad S (2011) Synthesis and analgesic effects of new pyrrole derivatives of phencyclidine in mice. Arzneimittelforschung 61:296–300CrossRefPubMedGoogle Scholar
  3. Biava M, Porretta GC, Poce G, Battilocchio C, Alfonso S, De Logu A, Serra N, Manetti F, Botta M (2010) Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin. Bioorg Med Chem 18:8076–8084CrossRefPubMedGoogle Scholar
  4. Borchhardt DM, Andricopulo AD (2009) CoMFA and CoMSIA 3D QSAR models for a series of cyclic imides with analgesic activity. Med Chem 5:66–73CrossRefPubMedGoogle Scholar
  5. Bush BL, Nachbar RB Jr (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput-Aided Mol Des 7:587–619CrossRefPubMedGoogle Scholar
  6. Cramer RD (1993) Partial Least Squares (PLS): its strengths and limitations. Perspect Drug Discov Des 1(2):269–278CrossRefGoogle Scholar
  7. Cramer RD (2003) Topomer CoMFA: a design methodology for rapid lead optimization. J Med Chem 46(3):374–388CrossRefPubMedGoogle Scholar
  8. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967CrossRefPubMedGoogle Scholar
  9. Cramer RD, Clark RD, Patterson DE, Ferguson AM (1996) Bioisosterism as a molecular diversity descriptor: steric fields of single “topomeric” confermres. J Med Chem 39(16):3060–3069CrossRefPubMedGoogle Scholar
  10. Dickey JB, Towne EB, Bloom MS, Moore WH, Hill HM, Heynemann H, Hedberg DG, Sievers DC, Otis MV (1959) Azo dyes from substituted 2-aminothiazoles. J Org Chem 24(2):187–196CrossRefGoogle Scholar
  11. Duncan K, Barry CE (2004) Prospects for new antitubercular drugs. Curr Opin Microbiol 7:460–465CrossRefPubMedGoogle Scholar
  12. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH (1998) Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36:362–366PubMedCentralPubMedGoogle Scholar
  13. Gorczynski MJ, Leal RM, Mooberry SL, Bushweller JH, Brown ML (2004) Synthesis and evaluation of substituted 4-aryloxy- and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of human breast cancer cell proliferation. Bioorg Med Chem 12:1029–1036CrossRefPubMedGoogle Scholar
  14. Goto S, Jo K, Kawakita T, Mitsuhashi S, Nishino T, Ohsawa N, Tanami H (1981) Determination method of minimum inhibitory concentrations. Chemotherapy 29:76–79Google Scholar
  15. Gundersen LL, Nissen-Meyer J, Spilsberg B (2002) Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines. J Med Chem 45:1383–1386CrossRefPubMedGoogle Scholar
  16. Jones RA (1992) Pyrroles, Vinyl Pyrroles, Part II, the chemistry of heterocyclic compounds, vol 48. Wiley, New York, pp 131–298Google Scholar
  17. Jones RA, Bean GP (1997) The chemistry of pyrroles. Academic Press, London, pp 51–57Google Scholar
  18. Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS (2008) Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems, a novel class of potential antibacterial and antitubercular agents. Eur J Med Chem 43:1989–1996CrossRefPubMedGoogle Scholar
  19. Joshi SD, Joshi A, Vagdevi HM, Vaidya VP, Gadaginamath GS (2010) Microwave assisted synthesis of some new quinolinylpyrrole derivatives as potential antibacterial and antitubercular agents. Indian J Heterocycl Chem 19:221–224Google Scholar
  20. Joshi SD, More Y, Vagdevi HM, Vaidya VP, Gadaginamath GS, Kulkarni VH (2013a) Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems a novel class of potential antibacterial, antifungal and antitubercular agents. Med Chem Res 22:1073–1089CrossRefGoogle Scholar
  21. Joshi SD, Manish K, Badiger A (2013b) Synthesis and evaluation of antibacterial and antitubercular activities of some novel imidazo[2,1-b][1,3,4]thiadiazole derivatives. Med Chem Res 22:869–878CrossRefGoogle Scholar
  22. Kamal A, Ramakrishna G, Lakshma Nayak V, Raju P, Subba Rao AV, Viswanath A, Vishnuvardhan MV, Ramakrishna S, Srinivas G (2012) Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents. Bioorg Med Chem 20:789–800CrossRefPubMedGoogle Scholar
  23. Mohamed MS, Kamel R, Fathallah SS (2011) Synthesis of new pyrroles of potential anti-inflammatory activity. Arch Pharm (Weinheim) 12:830–839CrossRefGoogle Scholar
  24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefPubMedGoogle Scholar
  25. Pattan SR, Ali MS, Pattan JS, Purohit SS, Reddy VVK, Nataraj BR (2006) Synthesis and microbiological evaluation of 2-acetanilido-4-arylthiazole derivatives. Indian J Chem 45(B):1929–1932Google Scholar
  26. Sbardella G, Mai A, Artico M, Loddo R, Setzuc MG, La Colla P (2004) Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480. Bioorg Med Chem Lett 14:1537–1541CrossRefPubMedGoogle Scholar
  27. Singh D, Srivastava M, Gyananchandran AK, Gokulan PD (2010) Synthesis and biological evaluation of some new phenylthiazole derivatives for their antimicrobial activities. J Curr Pharm Res 4:16–19Google Scholar
  28. Tripos International (2012) Sybyl-X 2.0. Tripos International, St. LouisGoogle Scholar
  29. Valadas E, Antunes F (2005) Tuberculosis, a re-emergent disease. Eur J Radiol 55:154–157CrossRefPubMedGoogle Scholar
  30. Vicini P, Geronikaki A, Incerti M, Busonera B, Poni G, Cabras CA, La Colla P (2003) Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. Bioorg Med Chem 11:4785–4789CrossRefPubMedGoogle Scholar
  31. World Health Organization (2008) Global tuberculosis control: surveillance, planning, and financing, WHO Report. WHO Press, GenevaGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Shrinivas D. Joshi
    • 1
  • Uttam A. More
    • 1
    • 2
  • Sheshagiri R. Dixit
    • 1
  • Haresh H. Korat
    • 1
  • Tejraj M. Aminabhavi
    • 1
  • Aravind M. Badiger
    • 3
  1. 1.Novel Drug Design and Discovery Laboratory, Department of Pharmaceutical ChemistryS.E.T.’s College of PharmacyHubli-DharwarIndia
  2. 2.Centre for Research and DevelopmentPrist UniversityThanjavurIndia
  3. 3.BDR Pharmaceuticals International Pvt. Ltd.BarodaIndia

Personalised recommendations